Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism Dopamine reuptake inhibitors, NET inhibitors(Norepinephrine transporter inhibitors), Serotonin reuptake inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
RegulationSpecial Review Project (CN) |
Molecular FormulaC21H33ClN2O |
InChIKeyRAIJPRKELCVSDI-GZMMRYBBSA-N |
CAS Registry1215292-99-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Obesity | Phase 1 | CN | 01 Feb 2017 | |
Obesity | Phase 1 | CN | 01 Feb 2017 |